重组干扰素α 1b雾化吸入治疗婴儿毛细支气管炎的临床疗效观察  

Clinical effect of recombinant interferon α 1b aerosol inhalation in the treatment of infant bronchiolitis

作　　者：符辰潞[1] 杨勇[1] 石筱蕾[1] 谢勇 Fu Chenlu;Yang Yong;Shi Xiaolei;Xie Yong(Department of Pediatrics,the First People's Hospital of Changzhou City 213000;Department of Pediatrics,Karamay Central Hospital 834000)

机构地区：[1]江苏省常州市第一人民医院儿科,213000 [2]新疆克拉玛依中心医院儿科,834000

出　　处：《中国社区医师》2017年第1期61-61,63,共2页Chinese Community Doctors

摘　　要：目的:探讨重组干扰素α1b雾化吸入治疗婴儿毛细支气管炎的效果。方法:收治毛细支气管炎患儿100例,随机分为对照组和观察组,对照组采用普米克和爱全乐雾化吸入治疗,观察组采用普米克、爱全乐、干扰素吸入治疗,比较两组治疗效果。结果:观察组临床症状缓解时间及住院率均优于对照组(P<0.05)。结论:重组干扰素α1b雾化吸入治疗婴儿毛细支气管炎的效果显著。Objective:To explore the clinical effect of recombinant interferonα1b aerosol inhalation in the treatment of infantbronchiolitis.Methods:100cases of infant bronchiolitis were selected.They were randomly divided into the control group and theobservation group.The control group was treated with pulmicort and atrovent aerosol inhalations.The observation group was treatedwith pulmicort,atrovent and interferon aerosol inhalation.We compared the therapeutic effect of two groups.Results:In theobservation group,the clinical symptom relief time and hospitalization rate were better than the control group(P<0.05).Conclusion:The clinical effect of recombinant interferonα1b aerosol inhalation in the treatment of infant bronchiolitis was significant.

关 键 词：毛细支气管炎 重组干扰素Α1B 雾化吸入 

分 类 号：R725.6[医药卫生—儿科]